Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Recruiting Observational Study
Intracerebral Hemorrhage (ICH)
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
University Hospital, Tours · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute manageme…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment; * Obtaining non-opposition Exclusion Criteria: * First brain imaging perfor…
Contacts

Marco PASI, Pr

2.47.47.80.21

m.pasi@chu-tours.fr

CONTACT

Sophie QUERAUD

247470156

s.queraud@chu-tours.fr

CONTACT